Q90.1
Trisomy 21, mosaicism (mitotic nondisjunction)
Clinical Classification Guidelines
Medical Intelligence & Overview
Trisomy 21, mosaicism, also known as Down syndrome mosaicism, is a genetic condition caused by the presence of an extra copy of chromosome 21 in some but not all cells of the body. Unlike typical Down syndrome, which involves a full extra chromosome 21 in every cell, mosaicism results in a mixture of cells—some with the usual two copies and others with three. This variation leads to a wide spectrum of physical and cognitive features, with many individuals experiencing milder characteristics. The condition results from a process during cell division called mitotic nondisjunction, which occurs after fertilization. This means the abnormal cell division happens early in development, leading to the mosaic pattern.
Causes & Symptoms
Clinical Causes: Mitotic nondisjunction during early embryonic cell division Error in cell division that results in some cells having an extra chromosome 21 Random genetic occurrence; generally not inherited No clear environmental or lifestyle factors have been linked to mosaic trisomy 21
Key Symptoms: Variable intellectual disability, often milder than typical Down syndrome Distinct facial features, such as almond-shaped eyes and a flat nasal bridge, may be less pronounced Possible heart defects or other physical anomalies, depending on the proportion of affected cells Delayed motor skills, speech, and language development Hypotonia, or decreased muscle tone Short stature compared to peers Increased risk of health issues like hearing and vision problems, thyroid conditions, or leukemia in some cases Behavioral challenges, including attention deficits or developmental delays
Diagnostic & Treatment
Diagnosis Path: Diagnosis of mosaic trisomy 21 often involves a combination of clinical evaluation and laboratory tests. Techniques such as karyotyping, fluorescence in situ hybridization (FISH), or microarray analysis can identify the presence and proportion of cells with an extra chromosome 21. Because mosaicism can vary widely, multiple tissue samples—such as blood, skin, or chorionic villus sampling—may be analyzed to understand the extent of the condition. Prenatal testing might reveal mosaicism; however, definitive diagnosis typically occurs after birth due to the complexity of detecting mosaic patterns.
Treatment Protocols: There is no cure for trisomy 21 mosaicism, but various interventions aim to support development and manage associated health issues. These may include: - Special education programs and speech therapy to aid learning and communication - Physical therapy to improve muscle tone and motor skills - Medical management of health conditions like heart defects, vision or hearing problems, and thyroid issues - Regular health screenings for early detection of potential complications - Support groups and counseling for individuals and families to address developmental and emotional challenges Treatment plans are personalized based on the individual's specific needs and the severity of symptoms.
Clinical Advice & FAQs
Billing Guidance
Is Q90.1 a billable ICD-10 code?
Yes, Q90.1 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report Q90.1?
Clinical documentation must specify the nature of Trisomy 21, mosaicism (mitotic nondisjunction) and any associated comorbidities for accurate reporting.
Cite this Clinical Reference